Overview

At the Forefront of Plant Biotechnology

Evogene is a leading developer of improved plants for the ag-biotech and biofuel industries.

The Company’s proprietary product development platform combines world leading computational gene discovery technology, green-house and field validation systems and advanced breeding methods. The platform’s computational biology component - the ATHLETE - is based on Compugen's (Nasdaq: CGEN) in-silico predictive discovery capabilities.

Evogene's current programs focus on the improvement of key plant traits, such as yield, environmental stress tolernace (such as drought), fertilizer utilization and the improvement of plants specifically for biofuel uses.

Evogene has collaboration and licensing agreements with world leading companies in the ag-biotech and alternative energy industries.

Evogene's headquarters are in Rehovot, Israel, and is traded on the Tel Aviv Stock Exchange (TASE:EVGN).